Antifibrinolytic agents for von Willebrand's disease
Content provided by Healthwise
Examples
| Brand Name | Generic Name |
| Amicar | aminocaproic acid |
| Brand Name | Generic Name |
| Cyklokapron | tranexamic acid |
Antifibrinolytic agents can be taken in pill or liquid form, applied to the skin (topically), or given as an injection into the vein (intravenously).
How It Works
Von Willebrand's disease is a bleeding disorder in which the blood does not clot properly. Antifibrinolytic agents help prevent blood clots from breaking down in certain areas of the body. These medications specifically target the mucous membranes of the mouth, nose, stomach, intestines, and urinary tract.
Why It Is Used
Health professionals usually use antifibrinolytic agents to treat nosebleeds and to prevent bleeding in the mouth during dental surgery. They may also use these medications in combination with desmopressin and plasma replacement therapies during minor and major surgery.
How Well It Works
Antifibrinolytic agents are especially effective in preventing or controlling mild bleeding in the mouth. Although they may be combined with preventive clotting factors to replace certain properties in your blood cells, very few studies confirm the benefit of this approach.1
Side Effects
Possible side effects of antifibrinolytic agents include:
- Upset stomach.
- Headache.
- Redness of the face and neck (flushing).
- Abnormally low blood pressure (hypotension).
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
What To Think About
Antifibrinolytic agents should be avoided if there is a risk of blood clots in the leg (deep vein thrombosis) or in the lungs (pulmonary embolism), or if bleeding is occurring in the urinary or genital systems.2
When used alone, these medications usually help control mild bleeding in the mouth, nose, stomach, intestines, or urinary tract.
Some people can use these medications instead of clotting factor replacement therapy after dental surgery.
Complete the new medication information form (PDF) (What is a PDF document?) to help you understand this medication.
References
Citations
Mannucci PM (2001). How I treat patients with von Willebrand disease. Blood, 97(7): 1915–1919.
Kessler CM (2004). Hemorrhagic disorders: Coagulation factor deficiencies. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed., vol. 1, pp. 1069–1075. Philadelphia: Saunders.
Credits
| Author | Debby Golonka, MPH |
| Editor | Susan Van Houten, RN, BSN, MBA |
| Associate Editor | Michele Cronen |
| Associate Editor | Pat Truman, MATC |
| Primary Medical Reviewer | Kathleen Romito, MD - Family Medicine |
| Specialist Medical Reviewer | Joseph O'Donnell, MD - Hematology/Oncology |
| Last Updated | November 29, 2006 |
| Last updated: | November 29, 2006 |
|---|---|
| Author: | Debby Golonka, MPH |
| Reviewed By: | Kathleen Romito, MD - Family Medicine, Joseph O'Donnell, MD - Hematology/Oncology |
| Editors: | Susan Van Houten, RN, BSN, MBA, Pat Truman, MATC |
© 1995-2007, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.
Search
Where Does it Hurt?
If you're experiencing aches and pains we can help you find answers. Find out what your symptoms mean for your health.
